PATIENTS AND METHODS

Patient selection
All patients (n = 5) had advanced Parkinson's disease with disabling symptoms; their mean age was 67.0 ± 5.6 years, the mean disease duration was 11.6 ± 6.9 years, and the mean Hoehn and Yahr stage when "off" was 3.9 ± 1.3 (the average of two preoperative assessments). Previous medical therapy had failed in all patients, and most of the patients had severe motor fluctuations with peak-dose dyskinesias or dystonia. (See Table 1 for baseline patient characteristics). All five patients had been treated by the investigators for at least 6 months before enrollment in the study. The risks, the benefits, and the experimental nature of the procedure were outlined in detail for each patient, and their written informed consent was obtained according to the guidelines of our institutional review board. 
Clinical assessment
Patients were evaluated 2 weeks and 1 week before surgery, and 2, 4, and 8 weeks after each surgical procedure. On each test date, the patients were first evaluated in a practically defined "off" state, with their last anti-parkinsonian medication taken at least 9 hours before the assessment. Patients then took their usual morning dose of levodopa, dopamine agonists, and anticholinergic medications, and they were again evaluated when "on." Assessments performed both on and off included a complete Unified Parkinson's Disease Rating Scale (UPDRS) (4), Hoehn and Yahr staging (12) , and the Schwab-England Activities of Daily Living scale (4) . Subscales were constructed from the individual items on the UPDRS to analyze akinesia, rigidity, and tremor, globally as well as on each side of the body. A Folstein Mini-Mental Status Examination (6) and Hamilton Depression Inventory (10) were completed also at each visit.
Timed tasks
Timed tasks of motor performance were also performed in the off and on states, as described previously by Lindvall et al. (15) . These included assessments of pronation-supination, hand opening and closing, fine finger movements, heel tapping, and gait.
Additional evaluations
Magnetic resonance imaging scans were obtained at baseline, within 1 week after surgery, and 4 weeks after each surgery. Computerized visual fields were obtained before the first surgical procedure for three patients and after the last surgical procedure for all patients. Patients were videotaped 1 week before and 4 weeks after all surgical procedures.
Surgical technique
Each patient underwent a unilateral pallidotomy as his or her initial surgical procedure. Patients 2 and 3 underwent repeated surgery on the same side, because early improvement and subsequent relapse suggested that the initial lesions might have been too small in size. Patients 1 and 4 had subsequent contralateral pallidotomies. Patient 5 had a single left pallidotomy.
For all procedures, target localizations were performed on the basis of the guidelines published by Laitinen et al. (14) . The preoperative target was planned on thin-slice magnetic resonance imaging to choose the optimal lesion placement (medial globus pallidum). Each initial radiographic target was then chosen on intraoperative computed tomography (1-mm scan thickness), with the gantry parallel to the anterior commissural-posterior commissural (AC-PC) line. Targets were chosen 2 mm anterior, 19 to 22 mm lateral, and 5 mm ventral to the AC-PC line. The Cosman-Roberts-Wells stereotactic instrument (Radionics, Inc., Burlington, MA) was used for the electrode placement (3). Patients received intravenous injections of propofol for sedation during the placement of the burr hole and the lesioning electrode. A single large burr hole was placed 2 cm lateral to the midline just posterior to the coronal suture, and the monopolar electrode was inserted (Radionics, Inc.) (1.2-mm diameter tip with 2-mm uninsulated length). In each patient, ventriculography with Isovue M-200 dye helped to confirm the electrode placement. Several lesions were made for each procedure, inserting the electrode deeper or withdrawing it by several millimeters; the final locations of the lesions depended on the patient's response to the electrical stimulation.
Intraoperative stimulation and lesioning protocol
For each potential lesion site, stimulation was first performed at low frequencies (23-5 Hz) and subsequently at higher frequencies (typically 50 Hz), starting with low voltage and increasing the voltage slowly. We paid close attention to any indication that a patient had visual hallucinations of flashing lights, which suggested that the tip of the lesioning electrode was too close to the optic tract. We also looked for evidence of clonic, tonic, or dystonic movement of the extremities or face, and we assessed for possible changes in speech.
Then, a physiological, reversible "mock" lesion was made by heating the electrode tip to 42°C. In most cases, this accurately predicted the response to the final anatomical lesion, and reversible improvement of contralateral rigidity and akinesia was noted.
A permanent anatomical lesion was made by heating the electrode tip to 72 to 80°C for up to 60 seconds. The electrode was moved in 2-mm increments, and the lesioning process was repeated to increase the overall lesion size. The total number of repetitions of this process depended on the patient's clinical response.
RESULTS
In all cases, magnetic resonance imaging was used postoperatively to verify the size and location of the globus pallidum lesion. The lesions were localized in three dimensions (x, y and z). Postoperative studies showed that all patients had lesions located between 17 and 21 mm lateral to the midline (x) and that all but one patient had lesions between 1 and 3 mm anterior to the midpoint of the AC-PC line (y) (Patient 2's lesion was 5 mm anterior). The vertical extent of the lesions on postoperative studies (z) varied among patients, despite the relatively uniform time of electrical lesioning among some patients in the group. The vertical extent of the lesions was specified as a distance, as the lesioning electrode was moved and multiple lesions were placed (mean, 15. 
CASE REPORTS
Patient 1
Patient 1, a 69-year-old, right-handed retired professor of political science, had first developed Parkinson's disease 14 years before this surgery. His first symptoms consisted of gait difficulty and foot dystonia. He initially responded to levodopa, but, as his disease progressed, he developed end-of-dose deterioration with bilateral foot dystonia, violent peak-dose dyskinesias, frequent falling caused by freezing, and marked deterioration of his handwriting. Trials on pergolide and bromocriptine had failed; by the time of his first surgery, he was taking a total daily dose of 1700 mg levodopa.
The first surgery for Patient 1 was right-sided pallidotomy. During surgery and immediately after surgery, observers noted marked improvement in left-sided foot dystonia, rigidity, and rapid alternating movements. No postoperative complications were noted during the week after surgery, and he had improvement in akinesia, tremor, rigidity, and dystonia on the left side. He complained of worsened speech, but the results of the physical examination did not confirm this. Peak-dose dyskinesias were improved on the left; however, his balance worsened, and he continued to fall frequently. Because of this, he increased his levodopa dose to a total of 2100 mg daily. On several occasions, he hit his head. Nine weeks after surgery a magnetic resonance imaging scan showed a substantial right convexity subdural hematoma, which was drained without complication. Because his worsened balance seemed to be caused by persistent right-foot dystonia and not to be a complication of his first surgery, he had a left-sided pallidotomy 11 weeks after the first pallidotomy and 2 weeks after drainage of the subdural hematoma.
During the left-sided pallidotomy and immediately after that surgery, patient 1 showed marked improvement in contralateral bradykinesia and motor tasks, and his voice was stronger. His gait did not improve significantly after the second surgery, although his right foot dystonia improved moderately. Speech was unequivocally improved; however, shortly after the second pallidotomy, he developed a severe clinical depression with suicidal ideation. His Hamilton Depression Inventory score rose from 8 before surgery to 17 after surgery. Visual field testing 12 weeks after his second surgery revealed an incongruent left homonymous hemianopsis that had not been noted on routine confrontation testing. He has increased his total daily dose of levodopa to 2500 mg and now finds it difficult to distinguish on and off states. He falls frequently because of persistent, severe freezing.
Patient 3
Patient 3, a 67-year-old, left-handed former store manager, had had Parkinson's disease for 4 years. When she was receiving levodopa, she developed peak-dose dystonic spasms of her left shoulder. By the time of surgery, she had profound left arm rigidity and had developed a frozen left shoulder. She also had left arm resting tremor, marked global bradykinesia, and bilateral dystonic foot inversion; she could stand only with assistance.
First, a right-sided pallidotomy was performed. Immediately after surgery, there was a marked improvement in left arm akinesia and rigidity. For the first 24 hours after surgery, a marked improvement in left arm mobility was observed; however, this early improvement diminished by the second day and disappeared completely by the third day after surgery. Because of the clear, although temporary, benefit seen on the first day after surgery, a second procedure was planned to enlarge the original lesion and provide a more lasting response.
Eight weeks later, a second right-sided pallidotomy was performed. The first of four lesions produced marked improvement in leftsided akinesia and rigidity, and subsequent lesions produced some additional incremental improvement. Finding that peak-dose dystonia of the left shoulder was drastically reduced over the next few months, the patient gradually increased her total daily levodopa dosage to 1800 mg with a great subjective improvement in overall function. Objectively, there was a marked reduction in shoulder dystonia. First, a right-sided pallidotomy was performed. Immediately after surgery, there was improved tone in the left arm and leg, with no complications. Peak-dose dyskinesias were essentially abolished on the left side of her body. Her Hoehn and Yahr stage, when off, improved from her preoperative stage 4.5 to stage 3, her stage when on improved from her preoperative stage 3 to stage 2. By 4 weeks after being discharged, she was doing much better. On time had increased, and off periods were shorter in duration and less frequent. Pergolide was increased to 1.5 mg a day. Some akathisia persisted, however. By 8 weeks after surgery, persistent right-sided dyskinesias were throwing the patient off balance when on. Because of her excellent response to the initial pallidotomy, and because her residual right-sided dyskinesias appeared to be the main cause for her ongoing disability, she was scheduled for contralateral pallidotomy.
Second, a left-sided pallidotomy was performed. During surgery and immediately after surgery, there was a significant decrease in tone in the right arm and leg. By the first postoperative day, there was a dramatic reduction in dyskinesia, and there appeared to be improvement in speech. Transient blurred vision in the right eye was noted; subsequently, formal visual field testing revealed a new deficit in the right superior quadrant. Depression was noted before she was discharged from the hospital, and, by 4 weeks after the surgery, the patient's score on Item 3 of the UPDRS, an indication of depression, had worsened from a score of 1 to 4.
Parkinson Rating Scale (all patients)
No differences were seen between the preoperative and postoperative results in either the mean UPDRS scores, or any of the traditional three subdivisions (mentation, activities of daily living [on or off], or motor examination [on or off]). Specific subscales were constructed to assess the following areas, both on and off: gait/posture, right-sided akinesia, left-sided akinesia, right-sided tremor, leftsided tremor, right-sided rigidity, and left-sided rigidity. Again, there were no differences between mean scores before and after surgery, either ipsilaterally or contralaterally. Timed tasks were normalized by taking the reciprocal of the time to complete a task, and additional hemibody subscales were constructed. No significant differences were observed before or after surgery in any areas, nor were any differences seen in the mean Schwab and England disability scores (on or off), the mean Hoehn and Yahr stages (on or off), or the mean Hamilton Depression Inventory scores (on or off) before and after unilateral pallidotomy.
Postoperative morbidity
Morbidity after unilateral ventroposterior medial pallidotomy included postoperative worsening of preexisting depression (n = 2), new visual field defects detected only on formal testing (n = 2), increased gait freezing (n = 1), worsened speech (n = 1), possibly worsened swallowing (n = 1), and transient facial weakness (n = 2). Both patients with depression had evidence of long-standing depression before any surgical intervention. Their depression may have been triggered by unmet expectations of surgery, rather than by any surgically created structural lesion.
DISCUSSION
The improvement in dyskinesias in Patients 1 and 4 and the improvement in dystonia in Patient 3 are consistent with previous reported experiences. Even in the years before levodopa was established as the standard treatment of Parkinson's disease, before the clinical syndrome of levodopa-induced peak-dose dyskinesias became endemic in the parkinsonian population, pallidotomy was investigated in the treatment of other choreiform and hemiballistic movements, with documented efficacy (7, 17) . More recently, other investigations have confirmed the effectiveness of pallidotomy in ameliorating hyperkinetic choreiform movements (2). Laitinen et al. (14) found a significant number of his patients had improvement in "dystonia/pain" and mentions that "pallidotomy had a very good effect on involuntary movement." More recently, others have confirmed the dramatic effect of pallidotomy on peak-dose dyskinesias (1, 5, 9, 18) .
Microelectrode recording may allow better anatomical and physiological localization of the appropriate target, as well as more precise definition of the boundary between the medial globus pallidus and the optic tract. Pallidotomy with microelectrode recording might therefore reduce the incidence of visual field deficits. Early reports from centers using this technique do not mention any field deficits, suggesting a possible advantage of this technique (5, 16, 18) . More significantly, a clearer definition of the boundaries between the medial globus pallidus and either the optic tract or the internal capsule might allow a larger lesion to be created with a greater margin of safety, thus allowing for greater functional improvement.
CONCLUSIONS
Ventroposterolateral pallidotomy can reduce or abolish contralateral peak-dose dyskinesia or dystonia in selected patients with Parkinson's disease. In at least one patient in the present study, we saw a dramatic improvement in the Hoehn and Yahr score, suggesting that this procedure has great potential. However, the benefit varies among patients, and the risks include visual field deficits and possible depression. The functional improvement in patients with advanced Parkinson's disease was not significant.
